• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖皮质激素诱导肿瘤坏死因子受体(GITR)-糖皮质激素诱导肿瘤坏死因子受体配体(GITRL)系统,是休克和炎症中的一个新角色。

GITR-GITRL system, a novel player in shock and inflammation.

作者信息

Krausz Ludovic Tibor, Bianchini Rodolfo, Ronchetti Simona, Fettucciari Katia, Nocentini Giuseppe, Riccardi Carlo

机构信息

Dipartimento di Medicina Clinica e Sperimentale, Sezione di Farmacologia, Tossicologia e Chemioterapia, Università di Perugia, Perugia, Italy.

出版信息

ScientificWorldJournal. 2007 May 1;7:533-66. doi: 10.1100/tsw.2007.106.

DOI:10.1100/tsw.2007.106
PMID:17525820
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5901298/
Abstract

Glucocorticoid-induced TNFR-Related (GITR) protein is a member of the tumor necrosis factor receptor superfamily that modulates acquired and natural immune response. It is expressed in several cells and tissues, including T cells, natural killer cells, and, at lower levels, in cells of innate immunity. GITR is activated by its ligand, GITRL, mainly expressed on antigen presenting and endothelial cells. Recent evidence suggests that the GITR/GITRL system participates in the development of inflammatory responses, including shock, either due to early response of neutrophils and macrophages, or together with autoimmune/allergic pathogenesis. The pro-inflammatory role of the GITR/GITRL system is due to: 1) modulation of the extravasation process, 2) activation of innate immunity cells, 3) activation of effector T cells also favored by partial inhibition of suppressor T cells and modulation of dendritic function. This review summarizes the in vivo role of the GITR/GITRL system in inflammation and shock, explaining the mechanisms responsible for their effects, considering the interplay among the different cells of the immune system and transduction pathways activated by GITR and GITRL triggering. The hidden aspects about GITR/GITRL function, crucial for treatment planning of inflammatory diseases and shock by modulation of this system is stressed.

摘要

糖皮质激素诱导的肿瘤坏死因子受体相关(GITR)蛋白是肿瘤坏死因子受体超家族的成员,可调节获得性免疫和天然免疫反应。它在多种细胞和组织中表达,包括T细胞、自然杀伤细胞,以及在先天免疫细胞中低水平表达。GITR由其配体GITRL激活,GITRL主要表达于抗原呈递细胞和内皮细胞。最近的证据表明,GITR/GITRL系统参与炎症反应的发生发展,包括休克,这要么是由于中性粒细胞和巨噬细胞的早期反应,要么是与自身免疫/过敏发病机制共同作用的结果。GITR/GITRL系统的促炎作用归因于:1)调节渗出过程;2)激活先天免疫细胞;3)通过部分抑制抑制性T细胞和调节树突状细胞功能,促进效应T细胞的激活。本综述总结了GITR/GITRL系统在炎症和休克中的体内作用,解释了其作用机制,考虑了免疫系统不同细胞之间的相互作用以及GITR和GITRL触发激活的信号转导途径。强调了GITR/GITRL功能中隐藏的方面,这对于通过调节该系统来治疗炎症性疾病和休克至关重要。

相似文献

1
GITR-GITRL system, a novel player in shock and inflammation.糖皮质激素诱导肿瘤坏死因子受体(GITR)-糖皮质激素诱导肿瘤坏死因子受体配体(GITRL)系统,是休克和炎症中的一个新角色。
ScientificWorldJournal. 2007 May 1;7:533-66. doi: 10.1100/tsw.2007.106.
2
GITR: a modulator of immune response and inflammation.GITR:免疫反应和炎症的调节剂。
Adv Exp Med Biol. 2009;647:156-73. doi: 10.1007/978-0-387-89520-8_11.
3
The GITRL-GITR system alters TLR-4 expression on DC during fungal infection.在真菌感染期间,GITRL-GITR系统会改变树突状细胞上TLR-4的表达。
Cell Immunol. 2009;257(1-2):13-22. doi: 10.1016/j.cellimm.2009.02.001. Epub 2009 Mar 9.
4
Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions.人源糖皮质激素诱导的TNF相关蛋白(GITR)配体介导的癌症免疫编辑:自然杀伤细胞与肿瘤细胞的相互作用
FASEB J. 2007 Aug;21(10):2442-54. doi: 10.1096/fj.06-7724com. Epub 2007 Mar 14.
5
GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory.GITR 配体融合蛋白激动剂增强了肿瘤抗原特异性 CD8 T 细胞应答,并导致持久的记忆。
J Immunother Cancer. 2017 Jun 20;5:47. doi: 10.1186/s40425-017-0247-0. eCollection 2017.
6
The Role of GITR/GITRL Interaction in Autoimmune Diseases.GITR/GITRL 相互作用在自身免疫性疾病中的作用。
Front Immunol. 2020 Oct 9;11:588682. doi: 10.3389/fimmu.2020.588682. eCollection 2020.
7
Identification of a ligand for glucocorticoid-induced tumor necrosis factor receptor constitutively expressed in dendritic cells.鉴定在树突状细胞中组成性表达的糖皮质激素诱导的肿瘤坏死因子受体的一种配体。
Biochem Biophys Res Commun. 2003 Oct 17;310(2):433-8. doi: 10.1016/j.bbrc.2003.09.024.
8
Glucocorticoid-induced tumor necrosis factor receptor family-related ligand triggering upregulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 and promotes leukocyte adhesion.糖皮质激素诱导的肿瘤坏死因子受体家族相关配体触发上调血管细胞黏附分子-1 和细胞间黏附分子-1,并促进白细胞黏附。
J Pharmacol Exp Ther. 2013 Oct;347(1):164-72. doi: 10.1124/jpet.113.207605. Epub 2013 Jul 26.
9
GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily.糖皮质激素诱导肿瘤坏死因子受体(GITR):一种属于肿瘤坏死因子受体超家族的免疫多面调节因子。
Eur J Immunol. 2005 Apr;35(4):1016-22. doi: 10.1002/eji.200425818.
10
Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation.对糖皮质激素诱导的肿瘤坏死因子受体(GITR)-糖皮质激素诱导的肿瘤坏死因子受体配体(GITRL)相互作用的基因和药理学抑制可减轻博来霉素滴注诱导的慢性肺损伤。
FASEB J. 2007 Jan;21(1):117-29. doi: 10.1096/fj.06-6611com. Epub 2006 Nov 29.

引用本文的文献

1
GITRL enhances cytotoxicity and persistence of CAR-T cells in cancer therapy.在癌症治疗中,糖皮质激素诱导的肿瘤坏死因子受体家族相关蛋白(GITRL)增强了嵌合抗原受体T细胞(CAR-T)的细胞毒性和持久性。
Mol Ther. 2025 Jun 4;33(6):2789-2800. doi: 10.1016/j.ymthe.2025.01.036. Epub 2025 Jan 25.
2
Innovative Therapies Targeting Drug-Resistant Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC).针对转移性透明细胞肾细胞癌(ccRCC)耐药生物标志物的创新疗法。
Int J Mol Sci. 2024 Dec 31;26(1):265. doi: 10.3390/ijms26010265.
3
Impact of Methylated Cyclodextrin KLEPTOSE CRYSMEB on Inflammatory Responses in Human In Vitro Models.甲基化环糊精 KLEPTOSE CRYSMEB 对人体外模型炎症反应的影响。
Int J Mol Sci. 2024 Sep 9;25(17):9748. doi: 10.3390/ijms25179748.
4
Targeting GITR in cancer immunotherapy - there is no perfect knowledge.在癌症免疫治疗中靶向 GITR- 没有完美的认识。
Oncotarget. 2023 Jun 19;14:614-621. doi: 10.18632/oncotarget.28461.
5
Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors.一项评估 GITR 激动剂抗体 TRX518 单药及联合吉西他滨、帕博利珠单抗或纳武利尤单抗治疗晚期实体瘤患者的 Ib 期研究。
Clin Cancer Res. 2022 Sep 15;28(18):3990-4002. doi: 10.1158/1078-0432.CCR-22-0339.
6
GITR/GITRL reverse signalling modulates the proliferation of hepatic progenitor cells by recruiting ANXA2 to phosphorylate ERK1/2 and Akt.GITR/GITRL 反向信号转导通过招募 ANXA2 磷酸化 ERK1/2 和 Akt 来调节肝祖细胞的增殖。
Cell Death Dis. 2022 Apr 4;13(4):297. doi: 10.1038/s41419-022-04759-z.
7
First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas.GWN323(抗 GITR)单药及联合 spartalizumab(抗 PD-1)治疗晚期实体瘤和淋巴瘤患者的 I/ Ib 期首次人体开放标签剂量递增研究。
J Immunother Cancer. 2021 Aug;9(8). doi: 10.1136/jitc-2021-002863.
8
Platelet-expressed immune checkpoint regulator GITRL in breast cancer.血小板表达的免疫检查点调节剂 GITRL 在乳腺癌中的作用。
Cancer Immunol Immunother. 2021 Sep;70(9):2483-2496. doi: 10.1007/s00262-021-02866-y. Epub 2021 Feb 4.
9
The Role of GITR/GITRL Interaction in Autoimmune Diseases.GITR/GITRL 相互作用在自身免疫性疾病中的作用。
Front Immunol. 2020 Oct 9;11:588682. doi: 10.3389/fimmu.2020.588682. eCollection 2020.
10
Glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) drives atherosclerosis in mice and is associated with an unstable plaque phenotype and cerebrovascular events in humans.糖皮质激素诱导的肿瘤坏死因子受体家族相关蛋白 (GITR) 可导致小鼠发生动脉粥样硬化,与人类不稳定斑块表型和脑血管事件相关。
Eur Heart J. 2020 Aug 14;41(31):2938-2948. doi: 10.1093/eurheartj/ehaa484.